We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




QR Bracelet Helps Patients Receive Better Treatment

By HospiMedica International staff writers
Posted on 02 May 2018
Bracelets imprinted with a quick response (QR) code may allow patients with rare diseases to receive improved treatment through immediate access to management protocols, claims a new study.

Developed by researchers at Newcastle University (United Kingdom) and Queen Elizabeth Hospital (Gateshead, United Kingdom) for people suffering from Addison's disease, the QR code, which is printed both on bracelets and on plastic cards carried by the patient, links to the Addison's Disease Information System (ADIS), which provides comprehensive clinical management advice specific to each patient, including emergency treatment that may be required, a letter from a medical consultant, and advice about preparation for surgery.

The study included a survey of 54 healthcare professionals, including doctors, nurses, paramedics, and dentists, who were asked about their experience in managing an adrenal crisis in Addison's disease patients and their professional views of the ADIS. More...
The results revealed that 37% of the healthcare professionals had never seen, and 59% had never managed such an adrenal crisis. Survey participants expressed a preference for QR code-linked information, and as many as 96% thought that ADIS would be helpful in an acute setting. The study was published on April 9, 2018, in BMJ Innovations.

“Rare medical conditions are prone to poor management in non-specialist units as, by definition, their presentation is uncommon. Some healthcare professionals do not feel they have the appropriate knowledge or confidence to manage these cases, and they may need more support from information systems such as ADIS,” said lead author Jolanta Weaver, PhD, of Newcastle University. “Our ADIS uses a web app running on a smart device, linked to a QR code. It is accessible at all times and shareable with healthcare professionals, patients, their carers, or when required in an emergency by bystanders.”

Addison’s disease is a rare chronic disorder of the adrenal glands resulting in inadequate production of cortisol, which is essential for blood pressure regulation, maintaining glucose levels, and the body’s response to stress. It is treated by daily tablets of prednisolone, a synthetic analogue of cortisol, and fludrocortisone, a synthetic analogue of aldosterone. But concurrent illness, surgery, missed, stopped, or malabsorbed medication can cause an adrenal crisis, a medical emergency that can be fatal if left untreated. Treatment involves intramuscular or intravenous hydrocortisone and further resuscitation with a saline infusion and hydrocortisone.

Related Links:
Newcastle University
Queen Elizabeth Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.